[1] |
Nalmpantis D, Gatou A, Fragkioudakis I, et al. Azurocidin in gingival crevicular fluid as a potential biomarker of chronic periodontitis[J]. J Periodontal Res, 2020, 55(2):209-214.
doi: 10.1111/jre.12703
pmid: 31608993
|
[2] |
Barros SP, Williams R, Offenbacher S, et al. Gingival crevicular fluid as a source of biomarkers for periodontitis[J]. Periodontol 2000, 2016, 70(1):53-64.
doi: 10.1111/prd.12107
|
[3] |
束蓉, 倪靖. 2018牙周病和植体周病国际新分类: 牙周炎分期分级疾病定义系统临床应用体会[J]. 口腔医学, 2020, 40(1):1-6.
|
[4] |
Olsen I, Lambris JD, Hajishengallis G. Porphyromonas gingivalis disturbs host-commensal homeostasis by changing complement function[J]. J Oral Microbiol, 2017, 9(1):1340085.
doi: 10.1080/20002297.2017.1340085
|
[5] |
Bechinger B, Gorr SU. Antimicrobial peptides: Mechanisms of action and resistance[J]. J Dent Res, 2017, 96(3):254-260.
doi: 10.1177/0022034516679973
pmid: 27872334
|
[6] |
Nuti R, Goud NS, Saraswati AP, et al. Antimicrobial peptides: A promising therapeutic strategy in tackling antimicrobial resistance[J]. Curr Med Chem, 2017, 24(38):4303-4314.
doi: 10.2174/0929867324666170815102441
pmid: 28814242
|
[7] |
Findlay F, Proudfoot L, Stevens C, et al. Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections[J]. Pathog Glob Heal, 2016, 110(4/5):137-147.
|
[8] |
Khurshid Z, Naseem M, Sheikh Z, et al. Oral antimicrobial peptides: Types and role in the oral cavity[J]. Saudi Pharm J, 2016, 24(5):515-524.
pmid: 27752223
|
[9] |
Zhang LJ, Gallo RL. Antimicrobial peptides[J]. Curr Biol, 2016, 26(1):R14-R19.
doi: 10.1016/j.cub.2015.11.017
|
[10] |
Wenzel M, Senges CHR, Zhang J, et al. Antimicrobial peptides from the aurein family form ion-selective pores in Bacillus subtilis[J]. Chem Bio Chem, 2015, 16(7):1101-1108.
doi: 10.1002/cbic.v16.7
|
[11] |
张溪, 弓磊. 抗菌肽抗菌机制及研究热点[J]. 中国组织工程研究, 2020, 24(10):1634-1640.
|
[12] |
Meade KG, O'Farrelly C. Β-defensins: Farming the microbiome for homeostasis and health[J]. Front Immunol, 2018, 9: 3072.
doi: 10.3389/fimmu.2018.03072
pmid: 30761155
|
[13] |
Hancock RE, Haney EF, Gill EE. The immunology of host defence peptides: Beyond antimicrobial activity[J]. Nat Rev Immunol, 2016, 16(5):321-334.
doi: 10.1038/nri.2016.29
pmid: 27087664
|
[14] |
Haney EF, Hancock REW. Peptide design for antimicrobial and immunomodulatoryapplications[J]. Pept Sci, 2013, 100(6):572-583.
doi: 10.1002/bip.v100.6
|
[15] |
Veldhuizen EJ, Schneider VA, Agustiandari H, et al. Antimicro-bial and immunomodulatory activities of PR-39 derived peptides[J]. PLoS One, 2014, 9(4):e95939.
doi: 10.1371/journal.pone.0095939
|
[16] |
王宏岩, 刘荩文, 李倩, 等. 唾液富组蛋白5抑制牙龈卟啉单胞菌与具核梭杆菌共聚的初步研究[J]. 中华口腔医学杂志, 2018, 53(3):150-156.
|
[17] |
武玮, 郝树立, 周玉森, 等. 牙周基础治疗对2型糖尿病伴慢性牙周炎患者血清生化指标及炎性细胞因子的影响[J]. 中华全科医学, 2020, 18(2):249-251, 281.
|
[18] |
李怀平, 梁丽平, 阎妍. 慢性牙周炎患者血清及龈沟液中炎性细胞因子的变化观察[J]. 疑难病杂志, 2014, 13(12):1297-1299.
|
[19] |
李居武, 夏宣童, 饶红艺. 牙周炎患者血清及龈沟液中多项炎性细胞因子的变化观察[J]. 川北医学院学报, 2015, 30(3):340-343.
|
[20] |
黄辉, 于大海, 罗智杰, 等. 牙周基础治疗对中重度牙周炎患者血清BDNF和炎症因子的影响[J]. 临床口腔医学杂志, 2021, 37(1):19-21.
|
[21] |
陈崇崇, 钟良军. 龈沟液生物标志物在慢性牙周炎诊疗中的研究进展[J]. 口腔医学, 2019, 39(11):1047-1052.
|
[22] |
张倩, 陈斌, 闫福华. 牙周基础治疗后龈沟液中4种生物标志物水平变化及临床意义[J]. 口腔疾病防治, 2021, 29(12):828-835.
doi: 10.12016/j.issn.2096-1456.2021.12.005
|
[23] |
Li P, Wohland T, Ho B, et al. Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an intermolecular disulfide bond in S3 dimer for binding, disruption, and neutralization of LPS[J]. J Biol Chem, 2004, 279(48):50150-50156.
doi: 10.1074/jbc.M405606200
pmid: 15328339
|
[24] |
王金良, 刘梦蝶, 谢丽敏, 等. 抗菌肽应用于不同牙周袋深度患牙的效果评估[J]. 中华老年口腔医学杂志, 2017, 15(5):280-285.
|
[25] |
邓涛. 2%盐酸米诺环素软膏治疗对牙周炎患者菌斑指数、牙周袋深度、临床附着丧失及牙龈指数的影响[J]. 湖南师范大学学报(医学版), 2019, 16(6):156-159.
|
[26] |
Wang HY, Lin L, Fu W, et al. Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production[J]. BMC Complement Altern Med, 2017, 17(1):426.
doi: 10.1186/s12906-017-1931-9
|